StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Credit Suisse Downgrades Allergen (AGN) to Neutral
January 31, 2019 4:56 AM
Credit Suisse analyst Vamil Divan downgraded Allergen (NYSE: AGN) from Outperform to Neutral with a price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Downgrades
Hot Downgrades
Next Articles
Allergen (AGN) PT Lowered to $200 at Mizuho Securities
January 30, 2019 8:21 AM
Allergen (AGN) PT Lowered to $181 at Raymond James
January 30, 2019 7:19 AM
Allergen (AGN) PT Lowered to $229 at Guggenheim
January 30, 2019 7:13 AM
Allergen (AGN) PT Lowered to $199 at BofA/Merrill Lynch
January 30, 2019 6:10 AM
Morgan Stanley Downgrades Allergen (AGN) to Equalweight
January 30, 2019 5:06 AM
Allergen (AGN) PT Lowered to $161 at Piper Jaffray
January 30, 2019 4:35 AM
Allergan (AGN) Tops Q4 EPS by 14c, Offers Q1 and FY Guidance, Approves $2B Buyback
January 29, 2019 7:04 AM
